- Home
- XNCR vs BLMN Comparison
XNCR vs BLMN Comparison
Compare XNCR & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- BLMN
- Stock Information
- Founded
- XNCR 1997
- BLMN 1988
- Country
- XNCR United States
- BLMN United States
- Employees
- XNCR N/A
- BLMN N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- BLMN Restaurants
- Sector
- XNCR Health Care
- BLMN Consumer Discretionary
- Exchange
- XNCR Nasdaq
- BLMN Nasdaq
- Market Cap
- XNCR 1.5B
- BLMN 1.4B
- IPO Year
- XNCR 2013
- BLMN 2012
- Fundamental
- Price
- XNCR $24.10
- BLMN $12.79
- Analyst Decision
- XNCR Strong Buy
- BLMN Hold
- Analyst Count
- XNCR 8
- BLMN 10
- Target Price
- XNCR $35.50
- BLMN $18.56
- AVG Volume (30 Days)
- XNCR 569.4K
- BLMN 2.2M
- Earning Date
- XNCR 11-06-2024
- BLMN 11-08-2024
- Dividend Yield
- XNCR N/A
- BLMN 7.50%
- EPS Growth
- XNCR N/A
- BLMN N/A
- EPS
- XNCR N/A
- BLMN N/A
- Revenue
- XNCR $85,164,000.00
- BLMN $4,547,161,000.00
- Revenue This Year
- XNCR N/A
- BLMN N/A
- Revenue Next Year
- XNCR $86.53
- BLMN $3.01
- P/E Ratio
- XNCR N/A
- BLMN N/A
- Revenue Growth
- XNCR N/A
- BLMN N/A
- 52 Week Low
- XNCR $15.31
- BLMN $12.26
- 52 Week High
- XNCR $26.84
- BLMN $30.13
- Technical
- Relative Strength Index (RSI)
- XNCR 70.71
- BLMN 31.75
- Support Level
- XNCR $22.60
- BLMN $12.26
- Resistance Level
- XNCR $23.86
- BLMN $13.90
- Average True Range (ATR)
- XNCR 0.83
- BLMN 0.77
- MACD
- XNCR 0.05
- BLMN -0.26
- Stochastic Oscillator
- XNCR 96.85
- BLMN 9.98
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.